Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05650645 · ClinicalTrials.gov registry record · Phase 2

The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial

A Phase 2 study of Tinnitus, sponsored by University of Minnesota.

Completed
Registry status
Phase 2
Development phase
41
Enrollment target
1
Study location

NCT05650645 is a Phase 2 study of Tinnitus that has completed, run by University of Minnesota. The registered enrollment target is 41 participants, below the 12,618-participant average among 24 other Tinnitus trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05650645, a Phase 2 study of Tinnitus, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
Phase 2
Development phase
41 participants
Enrollment target
1
Study location

Study Summary

Tinnitus is a persistent non-physiologic, non-psychiatric, ringing in the ear that affects up to 20% of the general US population. The purpose of this study is to assess the patient reported effectiveness of Xeomin (incobotulinumtoxinA) injections into the auricular muscles for relief of tinnitus with use of the Tinnitus Handicap Inventory questionnaire.

Conditions Studied

Tinnitus

Interventions

  • DRUG incobotulinum toxin A
  • DRUG Placebo-Saline

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2023-01-01
Est. Completion 2025-12-29
Phase Phase 2

Sponsor

University of Minnesota

966 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05650645

The ClinicalTrials.gov registry entry for NCT05650645 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,618-participant average among 24 other Tinnitus trials with a reported enrollment target (100% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tinnitus appearing as the primary indexed condition, and to 2 interventions - of which incobotulinum toxin A is the first listed.

NCT05650645 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05650645 about?

NCT05650645 is a clinical study titled "The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial". Tinnitus is a persistent non-physiologic, non-psychiatric, ringing in the ear that affects up to 20% of the general US population. The purpose of this study is to assess the patient reported effectiveness of Xeomin (incobotulinumtoxinA) injections into the auricular muscles for relief of tinnitus wi...

What is the current status of trial NCT05650645?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 41 participants. The study started on 2023-01-01. Estimated completion is 2025-12-29.

What conditions does trial NCT05650645 study?

This clinical trial studies the following conditions: Tinnitus.

What interventions are being tested in trial NCT05650645?

The interventions under investigation include: incobotulinum toxin A (DRUG), Placebo-Saline (DRUG).

Who is sponsoring clinical trial NCT05650645?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05650645 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Tinnitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Tinnitus

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.